Objectives: Senegal, with the support of WHO, had begun the establishment of a National Cancer Registry in 2009, although it had been at a standstill since 1969;the objective of this work was to test the reliability o...Objectives: Senegal, with the support of WHO, had begun the establishment of a National Cancer Registry in 2009, although it had been at a standstill since 1969;the objective of this work was to test the reliability of data collection tools and feasibility stages necessary for the validation of media before the establishment of a national cancer registry. Methodology: We conducted a non-exhaustive preliminary study over a period of three months from the first of January to 31 March 2010 at four major hospitals in Dakar at the time. Results: Two hundred and eighty-nine cases had been identified: 44% of men (n = 127) and 56% of women (n = 162) with a sex ratio of 0.8. The ages ranged from 20 to 90 years with an average of 50 years. The main diagnostic mode was essentially histological, with 76% of cases (n = 219). The most frequent locations were: ORL (ENT meaning Ear, Nose and Throat) with 25% of cases, liver 7% and bronchopulmonary 4.5% of cases. In men, liver cancer was the most common location and women for cervical cancer with 16%. Squamous cell carcinoma was the most common histological type with 68% of cases followed by adenocarcinoma with 22% of cases. Thirty-eight percent of patients were classified as stage III and IV. A quarter of our patients had received palliative treatment. In contrast, 15 (15%) had received chemotherapy and 4% had received radiotherapy. Data collection was satisfactory. Conclusion: Cancer is a reality in Senegal but it remains underdiagnosed. The materials made it possible to make the cancer registry effective throughout the country.展开更多
Background: Surgery is the treatment for early-stage cervical cancer. Radiochemotherapy is used in the treatment of locally advanced stages. But the choice of treatment can be difficult. Objective: The objective of th...Background: Surgery is the treatment for early-stage cervical cancer. Radiochemotherapy is used in the treatment of locally advanced stages. But the choice of treatment can be difficult. Objective: The objective of this work was to evaluate the therapeutic aspects of cervical cancer in the early stages IA to IIA in the oncology department of A Ledantec Hospital in Dakar. Patients and methods: This was a descriptive retrospective study, from January 2015 to December 2020, in the oncology department of A Ledantec Hospital, including all the patients who had been treated for early-stage invasive cervical cancer. Results: We included 28 patients. The average age was 49.54 years old. There were 11 patients (39.3%) with a stage ≤ IB1. Surgery was the first in 14 patients (50%). The initial approach was a midline supra and subumbilical laparotomy. The surgery was R0 in 65.22%. Postoperative complications were found in 4 patients including 1 case of operative wound suppuration, 1 case of dysuria, 1 case of postoperative eventration and 1 case of rectovaginal fistula. Concomitant Radiochemotherapy was neoadjuvant in 7 cases (25%), adjuvant in 14 cases (50%). The chemotherapy was neoadjuvant in 09 cases (56.25%) and adjuvant in 7 cases (43.75%) with minor toxicities. We had recorded 2 deaths. Conclusion: The treatment of the early stages of invasive cervical cancer is based on surgery. Neoadjuvant treatments may be useful in particular situations.展开更多
<strong>Introduction:</strong><span><span><span style="font-family:""><span style="font-family:Verdana;"> Cystic breast cancer is a rare entity. Breast cyst...<strong>Introduction:</strong><span><span><span style="font-family:""><span style="font-family:Verdana;"> Cystic breast cancer is a rare entity. Breast cysts are most often benign. The clinical characteristics of malignancy are not specific. </span><b><span style="font-family:Verdana;">Objective:</span></b> <span style="font-family:Verdana;">To report a series of malignant cystic tumors of the breast and to describe</span><span style="font-family:Verdana;"> their different characteristics. </span><b><span style="font-family:Verdana;">Materials and Methods:</span></b><span style="font-family:Verdana;"> This was an observational study carried out between January 2018 and October 2021 at the Dakar </span><span style="font-family:Verdana;">university surgical oncology unit. We studied the clinical appearance, im</span><span style="font-family:Verdana;">ag</span><span style="font-family:Verdana;">ing, </span><span style="font-family:Verdana;">histopathology, extent of disease and treatment. We did not include cases of</span><span style="font-family:Verdana;"> pure, single, or multiple chronically progressive cysts. </span><b><span style="font-family:Verdana;">Results:</span></b><span style="font-family:Verdana;"> There were 8 </span><span style="font-family:Verdana;">patients, 6 women and 2 men. The average age was 44. All patients presented </span><span style="font-family:Verdana;">with a palpable unilateral deforming skin mass without inflammatory </span><span style="font-family:Verdana;">character. One patient presented with a bloody discharge. The cyst was</span><span style="font-family:Verdana;"> multilocular with</span><span style="font-family:Verdana;">out intracystic growth in 2 cases and presented a growth signal in 6 cases.</span> <span style="font-family:Verdana;">Imaging was ACR 3 in 5 cases and ACR 4 in 3 cases. Histopathology found 6</span><span style="font-family:Verdana;"> in</span><span style="font-family:Verdana;">va</span><span style="font-family:Verdana;">sive carcinomas including 2 papillary, 3 Invasive Carcinoma of No Special</span><span style="font-family:Verdana;"> Type (ICNST), 1 lobular carcinoma as well as one case of lobular carcinoma </span><i><span style="font-family:Verdana;">in situ</span></i><span style="font-family:Verdana;"> of the comedocarcinoma type in women and 2 ICNST in men. The extension </span><span style="font-family:Verdana;">workup was found in only 1 male patient in the presence of metastases.</span><span style="font-family:Verdana;"> Treatment included chemotherapy, mastectomy and radiotherapy for 6 of </span><span style="font-family:Verdana;">the patients. There wasn’t any complete response for invasive cases. Survival is 100% to date.</span><span> <b><span style="font-family:Verdana;">Conclusion:</span></b><span style="font-family:Verdana;"> Cystic breast tumors sometimes hide the cancer</span></span><span style="font-family:Verdana;"> that is difficult to diagnose. The prognosis seems favorable, however.</span></span></span></span>展开更多
文摘Objectives: Senegal, with the support of WHO, had begun the establishment of a National Cancer Registry in 2009, although it had been at a standstill since 1969;the objective of this work was to test the reliability of data collection tools and feasibility stages necessary for the validation of media before the establishment of a national cancer registry. Methodology: We conducted a non-exhaustive preliminary study over a period of three months from the first of January to 31 March 2010 at four major hospitals in Dakar at the time. Results: Two hundred and eighty-nine cases had been identified: 44% of men (n = 127) and 56% of women (n = 162) with a sex ratio of 0.8. The ages ranged from 20 to 90 years with an average of 50 years. The main diagnostic mode was essentially histological, with 76% of cases (n = 219). The most frequent locations were: ORL (ENT meaning Ear, Nose and Throat) with 25% of cases, liver 7% and bronchopulmonary 4.5% of cases. In men, liver cancer was the most common location and women for cervical cancer with 16%. Squamous cell carcinoma was the most common histological type with 68% of cases followed by adenocarcinoma with 22% of cases. Thirty-eight percent of patients were classified as stage III and IV. A quarter of our patients had received palliative treatment. In contrast, 15 (15%) had received chemotherapy and 4% had received radiotherapy. Data collection was satisfactory. Conclusion: Cancer is a reality in Senegal but it remains underdiagnosed. The materials made it possible to make the cancer registry effective throughout the country.
文摘Background: Surgery is the treatment for early-stage cervical cancer. Radiochemotherapy is used in the treatment of locally advanced stages. But the choice of treatment can be difficult. Objective: The objective of this work was to evaluate the therapeutic aspects of cervical cancer in the early stages IA to IIA in the oncology department of A Ledantec Hospital in Dakar. Patients and methods: This was a descriptive retrospective study, from January 2015 to December 2020, in the oncology department of A Ledantec Hospital, including all the patients who had been treated for early-stage invasive cervical cancer. Results: We included 28 patients. The average age was 49.54 years old. There were 11 patients (39.3%) with a stage ≤ IB1. Surgery was the first in 14 patients (50%). The initial approach was a midline supra and subumbilical laparotomy. The surgery was R0 in 65.22%. Postoperative complications were found in 4 patients including 1 case of operative wound suppuration, 1 case of dysuria, 1 case of postoperative eventration and 1 case of rectovaginal fistula. Concomitant Radiochemotherapy was neoadjuvant in 7 cases (25%), adjuvant in 14 cases (50%). The chemotherapy was neoadjuvant in 09 cases (56.25%) and adjuvant in 7 cases (43.75%) with minor toxicities. We had recorded 2 deaths. Conclusion: The treatment of the early stages of invasive cervical cancer is based on surgery. Neoadjuvant treatments may be useful in particular situations.
文摘<strong>Introduction:</strong><span><span><span style="font-family:""><span style="font-family:Verdana;"> Cystic breast cancer is a rare entity. Breast cysts are most often benign. The clinical characteristics of malignancy are not specific. </span><b><span style="font-family:Verdana;">Objective:</span></b> <span style="font-family:Verdana;">To report a series of malignant cystic tumors of the breast and to describe</span><span style="font-family:Verdana;"> their different characteristics. </span><b><span style="font-family:Verdana;">Materials and Methods:</span></b><span style="font-family:Verdana;"> This was an observational study carried out between January 2018 and October 2021 at the Dakar </span><span style="font-family:Verdana;">university surgical oncology unit. We studied the clinical appearance, im</span><span style="font-family:Verdana;">ag</span><span style="font-family:Verdana;">ing, </span><span style="font-family:Verdana;">histopathology, extent of disease and treatment. We did not include cases of</span><span style="font-family:Verdana;"> pure, single, or multiple chronically progressive cysts. </span><b><span style="font-family:Verdana;">Results:</span></b><span style="font-family:Verdana;"> There were 8 </span><span style="font-family:Verdana;">patients, 6 women and 2 men. The average age was 44. All patients presented </span><span style="font-family:Verdana;">with a palpable unilateral deforming skin mass without inflammatory </span><span style="font-family:Verdana;">character. One patient presented with a bloody discharge. The cyst was</span><span style="font-family:Verdana;"> multilocular with</span><span style="font-family:Verdana;">out intracystic growth in 2 cases and presented a growth signal in 6 cases.</span> <span style="font-family:Verdana;">Imaging was ACR 3 in 5 cases and ACR 4 in 3 cases. Histopathology found 6</span><span style="font-family:Verdana;"> in</span><span style="font-family:Verdana;">va</span><span style="font-family:Verdana;">sive carcinomas including 2 papillary, 3 Invasive Carcinoma of No Special</span><span style="font-family:Verdana;"> Type (ICNST), 1 lobular carcinoma as well as one case of lobular carcinoma </span><i><span style="font-family:Verdana;">in situ</span></i><span style="font-family:Verdana;"> of the comedocarcinoma type in women and 2 ICNST in men. The extension </span><span style="font-family:Verdana;">workup was found in only 1 male patient in the presence of metastases.</span><span style="font-family:Verdana;"> Treatment included chemotherapy, mastectomy and radiotherapy for 6 of </span><span style="font-family:Verdana;">the patients. There wasn’t any complete response for invasive cases. Survival is 100% to date.</span><span> <b><span style="font-family:Verdana;">Conclusion:</span></b><span style="font-family:Verdana;"> Cystic breast tumors sometimes hide the cancer</span></span><span style="font-family:Verdana;"> that is difficult to diagnose. The prognosis seems favorable, however.</span></span></span></span>